JP2024520767A5 - - Google Patents

Info

Publication number
JP2024520767A5
JP2024520767A5 JP2023575452A JP2023575452A JP2024520767A5 JP 2024520767 A5 JP2024520767 A5 JP 2024520767A5 JP 2023575452 A JP2023575452 A JP 2023575452A JP 2023575452 A JP2023575452 A JP 2023575452A JP 2024520767 A5 JP2024520767 A5 JP 2024520767A5
Authority
JP
Japan
Prior art keywords
salt
lidocaine
pharmaceutical preparation
pharmaceutical formulation
preparation according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023575452A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024520767A (ja
Filing date
Publication date
Priority claimed from GB2107966.0A external-priority patent/GB2607584B/en
Application filed filed Critical
Publication of JP2024520767A publication Critical patent/JP2024520767A/ja
Publication of JP2024520767A5 publication Critical patent/JP2024520767A5/ja
Pending legal-status Critical Current

Links

JP2023575452A 2021-06-03 2022-06-01 Covid-19、自己免疫疾患、又はサイトカインストーム応答を処置するためのリドカイン又はアルチカイン Pending JP2024520767A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB2107966.0A GB2607584B (en) 2021-06-03 2021-06-03 Composition and method of treatment
GB2107966.0 2021-06-03
PCT/IB2022/055134 WO2022254363A1 (en) 2021-06-03 2022-06-01 Lidocaine or articaine for treating covid-19, autoimmune disease or cytokine storm response

Publications (2)

Publication Number Publication Date
JP2024520767A JP2024520767A (ja) 2024-05-24
JP2024520767A5 true JP2024520767A5 (cg-RX-API-DMAC7.html) 2025-06-02

Family

ID=76838703

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023575452A Pending JP2024520767A (ja) 2021-06-03 2022-06-01 Covid-19、自己免疫疾患、又はサイトカインストーム応答を処置するためのリドカイン又はアルチカイン

Country Status (6)

Country Link
US (1) US20240269109A1 (cg-RX-API-DMAC7.html)
EP (1) EP4346791A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024520767A (cg-RX-API-DMAC7.html)
CN (1) CN117715633A (cg-RX-API-DMAC7.html)
GB (1) GB2607584B (cg-RX-API-DMAC7.html)
WO (1) WO2022254363A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2639834A (en) * 2024-03-22 2025-10-08 Remicine Ip B V Composition and method of treatment

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994008550A1 (en) * 1992-10-09 1994-04-28 The Procter & Gamble Company Anaesthetic compositions
JP5111117B2 (ja) * 2005-12-22 2012-12-26 興和株式会社 ステロイドの経時的安定性が改善された外用製剤
TWI464148B (zh) * 2006-03-16 2014-12-11 Evotec Us Inc 作為p2x7調節劑之雙環雜芳基化合物與其用途
TWI395593B (zh) * 2008-03-06 2013-05-11 Halozyme Inc 可活化的基質降解酵素之活體內暫時性控制
CN103142643B (zh) * 2013-03-22 2014-07-02 新疆医科大学第一附属医院 Alha心脏停搏液及其制备方法
CN104127397B (zh) * 2014-08-19 2016-04-27 董颖颖 一种治疗急慢性过敏性及充血性皮肤病的药物及方法
CN106692120A (zh) * 2016-12-15 2017-05-24 刘力 利多卡因的药物组合物及其用途
CN111150738A (zh) * 2020-02-06 2020-05-15 西安交通大学医学院第二附属医院 一种治疗皮肤病的外用药物
CA3178140A1 (en) * 2020-03-31 2021-10-07 Nomoreitis B.V. Treatment of hyperinflammatory syndrome
RU2742505C1 (ru) * 2020-10-01 2021-02-08 Общество с ограниченной ответственностью "Институт термологии" Аэрозоль для инвазивной механической вентиляции легких при covid-19

Similar Documents

Publication Publication Date Title
AU2007298814B2 (en) Galenic form for the trans-mucosal delivery of active ingredients
ES2737976T3 (es) Forma farmacéutica para administración oral como tira u oblea comestible que contiene resina de intercambio iónico para enmascarar el sabor
EP2957282B1 (en) Oral antiseptic composition for treating oral mucositis
US6770263B1 (en) Compositions and methods for the treatment of aches and pains
JP6353577B2 (ja) 組み合わせ組成物
JP2019108362A (ja) ブプレノルフィンの乱用抵抗性粘膜付着性送達デバイス
US20080280947A1 (en) Anti-insomnia compositions and methods
CN1929816A (zh) 包含高浓度咪达唑仑的药用组合物
WO2017223566A1 (en) Compositions, devices, and methods for the treatment of alcohol use disorder
CN108697656A (zh) 洛沙平薄膜口服剂型
CN111065384A (zh) 扑热息痛的口腔崩解膜组合物
CN101460144A (zh) AchE-NMDA组合物干胶片
JP2024520767A5 (cg-RX-API-DMAC7.html)
JP2016505050A5 (cg-RX-API-DMAC7.html)
CN1132475A (zh) 鼻用释放芳香的组合物
JP2019516797A5 (cg-RX-API-DMAC7.html)
RU2018143564A (ru) Карбоновая кислота, предназначенная для лечения/предупреждения заложенности носа
CN105050610A (zh) 用于治疗咽喉痛、声嘶及相关的干咳以及治疗口腔和咽的炎性疾病的锭剂
US9801815B2 (en) Galenical form for the administration of triptans by buccal transmucous means
JP2019504040A (ja) 中等度〜重度のインフルエンザの処置
RU2519164C1 (ru) Способ профилактики и лечения химиолучевых стоматитов при химиолучевой терапии рака орофарингеальной области
TW201038296A (en) Ibuprofen lysinate oral suspension
CN104739661B (zh) 壳聚糖含漱液
TW201434495A (zh) 阿戈美拉汀(agomelatine)之頰給藥之固態醫藥組合物
EA202000232A1 (ru) Спрей для перорального применения, содержащий силденафила цитрат